CSPC Pharmaceutical Group Limited (OTCMKTS:CSPCY – Get Free Report) was the recipient of a large decrease in short interest during the month of January. As of January 15th, there was short interest ...

CSPC Pharmaceutical Group Limited announced that its SYH2059 Tablets have received clinical trial approval in China. This product, a PDE4B inhibitor, has shown superior efficacy and safety in ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

CSPC Pharmaceutical Group (HK:1093) has released an update. Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks! Easily identify outperforming stocks and invest smarter ...

Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks CSPC Pharmaceutical Group has received approval from China’s National Medical Products Administration to ...

Jefferies analyst David Shang maintained a Hold rating on CSPC Pharmaceutical Group (CHJTF – Research Report) today and set a price target of ...

Global markets have shown resilience, with major U.S. stock indexes rebounding and European stocks rising sharply amidst easing inflation concerns, while Japan's markets faced a downturn due to ...

all in one place with Analyst Top Stocks Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter CSPC Pharmaceutical Group’s breakthrough therapy, SYS6010 ...